Skip to main content

SoonerSelect enrollment is open through June 13! It’s your chance to pick or change your health and dental plans. Make changes in the member portal or call 800-987-7767.

Genitourinary System

Benign Prostatic Hyperplasia (BPH) Medications

Tier 1 products are covered with no authorization necessary.

Tier 2 Prior Authorization criteria

  • FDA approved diagnosis.
  • Recent 4-week trial of at least two Tier 1 medications from different pharmacological classes within the last 90 days.
  • Documented adverse effect, drug interaction, or contraindication to all available Tier 1 products.

Tier 3 Prior Authorization Criteria

  • FDA approved diagnosis of BPH.
  • Trial of at least two Tier 1 medications from different pharmacological classes.
  • A 4-week trial of each Tier 2 medication within the past 5 months.
  • Documented adverse effect, drug interaction, or contraindication, or lack of efficacy to all available Tier 1 and Tier 2 products.
  • Authorizations for tadalafil (Cialis®) will be granted for 5mg tablets only.
Tier 1
 Tier 2 Tier 3
  • alfuzosin (Uroxatrol®)
  • doxazosin (Cardura®)
  • finasteride (Proscar®)
  • tamsulosin (Flomax®)
  • terazosin (Hytrin®)
  • doxazosin (Cardura XL®)
  • dutasteride (Avodart®)
  • dutasteride/tamsulosin (Jalyn®)
  • silodosin (Rapaflo®)
  • tadalafil (Cialis®)
 Bladder Control Drugs 

Tier 1 products are covered with no authorization necessary.

Tier 2 authorization criteria

  • Trials of all Tier 1 medication that yielded inadequate clinical response or adverse effects, OR
  • A unique FDA approved indication not covered by Tier 1 products.

Tier 3 Authorization Criteria:

  • Trials of all Tier 2 medications that yielded inadequate clinical response or adverse effects, OR
  • A unique FDA approved indication not covered by lower Tiered products.
Tier 1 Tier 2 Tier 3
  • oxybutynin (Ditropan®)
  • oxybutynin ER tabs (Ditropan XL®)
  •  
  • tolterodine (Detrol®)
  • trospium (Sanctura™)
  •  
  • tolterodine ER tabs (Detrol LA®)
  • darifenacin (Enablex®)
  • oxybutynin Gel (Gelnique™)
  • mirabegron (Myrbetriq™)
  • oxybutynin patch (Oxytrol®)
  • trospium ER (Sanctura XR™)
  • fesoterodine (Toviaz™)
  • flavoxate (Urispas®)
  • solifenacin (VESIcare®)
*Tier-1 products are available without a prior authorization for all members. Hyoscyamine is available without prior authorization and can be used as adjunctive therapy, but does not count as a Tier-1 trial.
Last Modified on Sep 17, 2021
Back to Top
Back to top

Oklahoma Health Care Authority

4345 N Lincoln Blvd

Oklahoma City, OK 73105

Contact Us

The Oklahoma Health Care Authority collects the personally identifiable data submitted and received in regard to applications for services, renewals, appeals, provision of health care and processing of claims. This data is treated as confidential and is stored securely in accordance with applicable law and regulations. OHCA may share this personally identifiable data with its authorized business associates, government agencies with jurisdiction over the OHCA, or as otherwise required or permitted by applicable law.